Blue Trust Inc. Boosts Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Blue Trust Inc. grew its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 438.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,433 shares of the real estate investment trust’s stock after purchasing an additional 1,167 shares during the period. Blue Trust Inc.’s holdings in Omega Healthcare Investors were worth $58,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 1,030.8% in the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares during the last quarter. Marshall Wace LLP bought a new position in shares of Omega Healthcare Investors in the 2nd quarter worth $20,962,000. BROOKFIELD Corp ON purchased a new stake in shares of Omega Healthcare Investors during the 1st quarter valued at $16,446,000. Dimensional Fund Advisors LP lifted its holdings in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after acquiring an additional 272,299 shares during the last quarter. Finally, Sei Investments Co. grew its position in Omega Healthcare Investors by 150.8% in the second quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock worth $10,233,000 after acquiring an additional 179,623 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock opened at $42.43 on Friday. The company’s fifty day simple moving average is $40.42 and its two-hundred day simple moving average is $35.89. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The firm has a market cap of $10.94 billion, a PE ratio of 31.20, a price-to-earnings-growth ratio of 1.34 and a beta of 1.00. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The business had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.74 earnings per share. As a group, equities analysts expect that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.32%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on OHI. Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Scotiabank lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. BMO Capital Markets increased their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Finally, BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $39.70.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.